TrialLancet (London, England)2018

Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.

Lutz Heinemann et al.PubMed ↗Publisher ↗

No numbers read from the abstract.